Lord, Abbett & Co’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-85,549
| Closed | -$5.2M | – | 573 |
|
|
2022
Q2 | $5.2M | Buy |
+85,549
| New | +$5.2M | 0.02% | 488 |
|
|
2021
Q1 | – | Sell |
-307,320
| Closed | -$47.1M | – | 649 |
|
|
2020
Q4 | $47.1M | Buy |
307,320
+14,279
| +5% | +$2.19M | 0.12% | 258 |
|
|
2020
Q3 | $24.5M | Buy |
293,041
+18,124
| +7% | +$1.52M | 0.08% | 343 |
|
|
2020
Q2 | $20.2M | Sell |
274,917
-16,457
| -6% | -$1.21M | 0.07% | 370 |
|
|
2020
Q1 | $12.4M | Buy |
291,374
+8,940
| +3% | +$379K | 0.05% | 390 |
|
|
2019
Q4 | $17.2M | Sell |
282,434
-74,587
| -21% | -$4.54M | 0.06% | 424 |
|
|
2019
Q3 | $14.6M | Buy |
+357,021
| New | +$14.6M | 0.05% | 467 |
|
|
2018
Q3 | – | Sell |
-225,970
| Closed | -$13.3M | – | 835 |
|
|
2018
Q2 | $13.3M | Buy |
+225,970
| New | +$13.3M | 0.04% | 573 |
|
|
2017
Q1 | – | Sell |
-211,700
| Closed | -$4.29M | – | 870 |
|
|
2016
Q4 | $4.29M | Buy |
+211,700
| New | +$4.29M | 0.01% | 764 |
|